Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses

Nanovaccines, co-delivering antigen and invariant natural killer T (iNKT) cell agonists, proved to be very effective in inducing anti-tumor T cell responses due to their exceptional helper function. However, it is known that iNKT cells are not equally present in all lymphoid organs and nanoparticles...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Oncoimmunology
Κύριοι συγγραφείς: Dölen, Yusuf, Valente, Michael, Tagit, Oya, Jäger, Eliezer, Van Dinther, Eric A. W., van Riessen, N. Koen, Hruby, Martin, Gileadi, Uzi, Cerundolo, Vincenzo, Figdor, Carl G.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Taylor & Francis 2020
Θέματα:
Back Matter
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7790498/
https://ncbi.nlm.nih.gov/pubmed/33457086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1738813
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια